http://ADPHARMA.NET
ADPHARMACEUTICALS1 5847dbd200671109b8397d6c False 301 20
OK
background image not found
Found results for
'hcv genotypes'
Velpanat INR   0 INR  0
-NaN%

Velpanat

Velpanat medication is a combination of sofosbuvir and velpatasvir. This drug work by reducing the amount of hepatitis C virus in your body, which helps your immune system fight the infection and may help your liver recover. Sofosbuvir and Velpatasvir (Velpanat) is used to treat chronic (long-lasting) hepatitis C, a viral infection of the liver. It may sometimes be used with another antiviral medication (ribavirin). Velpanat is a prescription drugs. This drug is available in a tablets form and is a combination of Velpatasvir 100 mg and Sofosbuvir 400 mg. This combination of two leading salt is really work wonders when it comes to the patients suffering from Hepatitis C. Patients can have this particular drug in the form of a single tablet on a daily basis. This drug is the first treatment of its kind that operates on all the genotypic 1 to 6 HCV in a successful manner. Hetero Velpanat is very helpful for the treatment of those people who are affected by the ailment of chronic Hepatitis C. This drug is sold under the brand name Velpanat and the main active ingredients in this drug are Velpatasvir and Sofosbuvir in the different quantities. Natco Pharma manufactures Velpanat in India and is sold in a bottle with the packing of 28 tablets. Velpanat medicine has been proved very effective for the patients with the chronic Hepatitis C. Being the combination of two different drugs, it has proved to be effective in the treatment of different regimes related to Hepatitis C and does the anti HCV activity in a significant manner leading to the cure of the Hepatitis C ailment.

INR 0 INR 0

Availability:True

Pay mode:COD only

view details
Velasof USD   0 USD  0
-NaN%

Velasof

Velasof medication is a combination of sofosbuvir and velpatasvir. This drug work by reducing the amount of hepatitis C virus in your body, which helps your immune system fight the infection and may help your liver recover. Sofosbuvir and Velpatasvir is used to treat chronic (long-lasting) hepatitis C, a viral infection of the liver. It may sometimes be used with another antiviral medication (ribavirin). Velasof is a prescription drugs. This drug is available in a tablets form and is a combination of Velpatasvir 100 mg and Sofosbuvir 400 mg. This combination of two leading salt is really work wonders when it comes to the patients suffering from Hepatitis C. Patients can have this particular drug in the form of a single tablet on a daily basis. This drug is the first treatment of its kind that operates on all the genotypic 1 to 6 HCV in a successful manner. Hetero Velasof is very helpful for the treatment of those people who are affected by the ailment of chronic Hepatitis C. This drug is sold under the brand name Velasof and the chief active ingredients in this drug are Velpatasvir and Sofosbuvir in the different quantities. The manufacturing company of this medicine is Hetero Healthcare Limited in India and is sold in a bottle with the packing of 28 tablets. Velasof medicine has been proved very effective for the patients with the chronic Hepatitis C. Being the combination of two different drugs, it has proved to be effective in the treatment of different regimes related to Hepatitis C and does the anti HCV activity in a significant manner leading to the cure of the Hepatitis C ailment.

USD 0 USD 0

Availability:True

Pay mode:COD only

view details
Hepcinat - LP INR   0 INR  0
-NaN%

Hepcinat - LP

We are pioneer supplier of Hepcinat to Russia. HEPCINAT-LP contains polymerase inhibitors which called sofosbuvir and ledipasvir . Hepcinat-LP manufactured by Natco Pharma and approved for treatment of patients infected with Hepatitis C (HCV genotypes 1 and 4). Sofosbuvir & Ledipasvir is FDA-approved and EASL recommended treatment protocol for HCV, which does not include interferon or ribavirin. The clinical trials have proven very high success rate of sofosbuvir in combination with ledipasvir. Hepcinat-LP Tablets is a formulation combination of anti-viral medications Ledipasvir and Sofosbuvir used in the treatment of Chronic Hepatitis C Virus (CHCV) infection genotype 1. Hepcinat-LP is a prescription medicine containing Ledipasvir (90mg) a viral NS5A inhibitor and Sofosbuvir (400mg) a nucleotide inhibitor of the viral RNA polymerase. In one of official clinical trials involved more than 1,600 people with HCV genotype 1. The course of treatment was only 84 days. By the end of therapy 1556 patients achieved the primary target – absence of the virus. Adverse events that occurred in patients receiving sofosbuvir together with ledipasvir were mild and generally accompanied by headache and fatigue. Working pattern: Sofosbuvir+ledipasvir targetly affects to specific proteins involved in viral replication and thus totally stop the disease.

INR 0 INR 0

Availability:True

Pay mode:COD only

view details
Hepcinat 400 mg INR   0 INR  0
-NaN%

Hepcinat 400 mg

We are one of the main exporters of Hepcinat and we have been shipping Hepcinat to our clients in Russia on regular basis. Hepcinat 400 mg (Sofosbuvir) is an anti-viral medication used in the treatment of Hepatitis C Virus (HCV) infection. Hepcinat is a prescription drug containing Sofosbuvir 400 mg that help inhibit the RNA polymerase that the Hepatitis C Virus uses to replicate its RNA. Hepcinat is generally used in combination with other anti-viral medications as an oral dual therapy for Hepatitis C Virus (HCV) Genotypes 2 and 3 infection. Hepcinat is available as a 400 mg tablet. The recommended dose of sofosbuvir is 400 mg taken orally once daily, with or without food. The 400 mg dose of sofosbuvir should be used, regardless of the patient's genotype and prior hepatitis C treatment experience. No dose adjustment is needed for mild-to-moderate renal impairment or with mild, moderate, or severe hepatic impairment.

INR 0 INR 0

Availability:True

Pay mode:COD only

view details
Natdac 60 mg INR   0 INR  0
-NaN%

Natdac 60 mg

We are leading exporter of Natdac to Russia. Natdac (Daclatasvir Dihydrochloride) is a treatment for chronic hepatitis C virus (HCV) genotype 1 or genotype 3 infection. It is always prescribed with sofosbuvir, and depending on the genotype and underlying medical conditions, with or without ribavirin. Daclatasvir (NatDac) is the first-in-class NS5A inhibitor used in combination with Sofosbuvir for the treatment of patients with chronic hepatitis C virus (HCV) genotype 3 infection. Compared to other treatment options, this combination not only increases the cure rate, but is also regarded as a valuable treatment option in some of the difficult-to-treat HCV patient subsets. NATDAC 60 mg - Brand Name: Natdac Content: Daclatasvir Manufactured by: Natco Pharma Ltd. Strengths: 60 mg Form: Tablets Packing: Pack of 28 Tablets

INR 0 INR 0

Availability:True

Pay mode:COD only

view details
Resof 400 mg INR   0 INR  0
-NaN%

Resof 400 mg

We are one of the leading exporters of Resof to Russia. Resof 400mg (Sofosbuvir) is a nucleotide analog inhibitor of hepatitis C virus NS5B polymerase - the key enzyme mediating HCV RNA replication. This triphosphate compound mimics the natural cellular uridine nucleotide and is incorporated by the HCV RNA polymerase into the elongating RNA primer strand, resulting in chain termination. Resof 400mg is available as a 400 mg tablet. The recommended dose of sofosbuvir is 400 mg taken orally once daily, with or without food. The 400 mg dose of sofosbuvir should be used, regardless of the patient's genotype and prior hepatitis C treatment experience. No dose adjustment is needed for mild-to-moderate renal impairment or with mild, moderate, or severe hepatic impairment. Resof 400mg has been very well-tolerated in clinical trial. The most common adverse effects observed with sofosbuvir, when used in combination with ribavirin, have been fatigue and headache. Sofosbuvir is pregnancy category B.

INR 0 INR 0

Availability:True

Pay mode:COD only

view details
Resof - L INR   0 INR  0
-NaN%

Resof - L

We are main supplier of Resof-L to Russia. Resof-L Tablets is a anti-viral medications. Resof-L is a combination medicine having Ledipasvir and Sofosbuvir which is used in the treatment of Chronic Hepatitis C Virus (CHCV) infection genotype 1. Resof-L is a prescription medicine containing Ledipasvir (90mg) a viral NS5A inhibitor and Sofosbuvir (400mg) a nucleotide inhibitor of the viral RNA polymerase. The international brand name of this medicine is Harvoni that provides effective treatment in Hepatitis C. Resof-L helps prevent Hepatitis C Virus infection from multiplying or increasing in human body by weakening the virus and inhibiting its reproduction and replication. Dosage & Administration - As recommended by your doctor / physician / medical practitioner.

INR 0 INR 0

Availability:True

Pay mode:COD only

view details
1
false